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Bioluminescent detection 
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in microfluidic generated droplets 
and artificial cells
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Oliver K. Castell2
Microfluidic droplet generation affords precise, low volume, high throughput opportunities for 
molecular diagnostics. Isothermal DNA amplification with bioluminescent detection is a fast, low-
cost, highly specific molecular diagnostic technique that is triggerable by temperature. Combining 
loop-mediated isothermal nucleic acid amplification (LAMP) and bioluminescent assay in real time 
(BART), with droplet microfluidics, should enable high-throughput, low copy, sequence-specific DNA 
detection by simple light emission. Stable, uniform LAMP–BART droplets are generated with low 
cost equipment. The composition and scale of these droplets are controllable and the bioluminescent 
output during DNA amplification can be imaged and quantified. Furthermore these droplets are 
readily incorporated into encapsulated droplet interface bilayers (eDIBs), or artificial cells, and the 
bioluminescence tracked in real time for accurate quantification off chip. Microfluidic LAMP–BART 
droplets with high stability and uniformity of scale coupled with high throughput and low cost 
generation are suited to digital DNA quantification at low template concentrations and volumes, 
where multiple measurement partitions are required. The triggerable reaction in the core of eDIBs can 
be used to study the interrelationship of the droplets with the environment and also used for more 
complex chemical processing via a self-contained network of droplets, paving the way for smart soft-
matter diagnostics.
The ability to amplify, detect with high sensitivity and quantify specific nucleic acid sequences is an important 
and well established sector of the multibillion dollar molecular diagnostic industry which is expected to continue 
to grow to a market of 12.5 billion US  dollars1 by 2025. The benchmark DNA amplification method is the quan-
titative polymerase chain reaction (qPCR) which detects and quantifies DNA target sequences in real time. The 
ability to increase the quantity of specific DNA sequences has enabled the detection of particular traits that would 
otherwise remain undetected and has benefitted a wide range of areas from infectious disease diagnosis and 
oncology, to the identification of genetically modified organisms, and “DNA fingerprinting” in forensic science. 
In low resource settings and at point-of-care this is particularly desirable. To do this a thermostable polymerase 
enzyme is required to synthesize nascent DNA through cycles of temperature change. The Covid-19 pandemic 
has also highlighted the challenges with mass, centralised, qPCR diagnostics in otherwise well-resourced nations, 
where readily scalable point-of-care diagnostics could provide an  alternative2.
Due to the challenges posed by the requirement of thermocycling, notably challenging in a microfluidic 
context, there has been increasing interest in the development of isothermal DNA amplification  methods3–5. The 
most widely reported method is loop-mediated amplification (LAMP)6 which has been shown to be rapid, highly 
 specific7 and  sensitive8, with a greater tolerance to PCR  inhibitors9–11 frequently encountered in clinical samples, 
thus allowing less stringent DNA extractions or sample clean up. In principle throughput of this method can be 
increased using droplet microfluidics. A schematic of LAMP amplification is shown in Fig. 1 together with the 
concept of its application in droplets. In principle detection of as little as a single copy of DNA is achieved via 
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loop-amplification followed by detection of subsequently emitted light. Briefly, loop forming primers FIP and 
BIP (forward and backward inner primers) invade the double stranded DNA and are extended by a displacement 
polymerase enzyme. The newly formed DNA is displaced by further primers B3 and F3 to initiate amplification, 
with continuation of this process leading to the formation of complex looped structures. The LAMP reaction 
can also be accelerated with additional  Loop12 or  STEM13 primers. A by-product of DNA synthesis is inorganic 
pyrophosphate (PPi) produced in significant exponential quantities by the prolific LAMP reaction, and which 
can subsequently be used for detection.
The high concentration of pyrophosphate generated by LAMP is ideally suited towards bioluminescent assay 
in real time (BART)  reporter14 quantification. Here, the pyrophosphate is catalysed into adenosine triphosphate 
(ATP) in an ELIDA  reaction15 which is then converted to bioluminescence through a thermostable luciferase 
reaction (Fig. 1a). Quantification of DNA is realized here via the production of a peak in light intensity, of which 
timing is inversely proportional to the original DNA template  concentration14. Upon realization of the biolumi-
nescent peak, inhibition of bioluminescence occurs rapidly as a combined result of the depletion of adenosine-5′-
O-phosphosulfate (APS) which is required to convert the PPi to ATP and the concomitant accumulation of PPi 
which also inhibits luciferase at high concentrations. Light output from a positive sample is thereby characterised 
by a growth in the rate of light emission as DNA is amplified before falling below the baseline of negative controls 
Figure 1.  Schematic of LAMP BART reaction and droplet generation. (a) Schematic of LAMP BART 
bioluminescent droplet generation; aqueous LAMP BART droplets are formed at a microfluidic T-junction with 
an immiscible oil phase. Upon heating, the increase in bioluminescence from target DNA containing droplets is 
characterized by a peak in light output before inhibition by an excess of the by-product of DNA amplification, 
pyrophosphate, (b) simplified loop-mediated amplification (LAMP) schematic showing the three main stages, 
amplification initiation, cycling of “dumbbell” structures and elongation of looped concatemers, representation 
of the bioluminescent assay in real time (BART) showing the conversion of pyrophosphate into light and BART 
profiles for positive and negative samples.
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due to luciferase inhibition or APS depletion. Negative samples are characterised by a continuous baseline level 
of bioluminescence. BART is not appropriate for end-point detection due to the observation that the light output 
from the positive sample can be higher or lower than the negative sample at any one time point.
In contrast with PCR, LAMP–BART reactions can typically be performed isothermally at 60 °C, and can 
produce real-time results within a few minutes that are easily detected by photodiode or simple CCD camera 
imaging. Furthermore, BART detection is closed tube format which is highly applicable for use in an encapsulated 
droplet chemistry, whilst also reducing the risk of amplified DNA contamination. Also LAMP–BART has been 
employed to detect DNA template at the single molecule  level8 and has recently been shown to be applicable 
to single and low copy number  quantification16. These features provide significant benefits over the more com-
monly used PCR in terms of ease of quantification and sample amenability, with no compromise in measurement 
sensitivity for point-of-care application.
Microfluidic approaches have long been applied to DNA amplification methods, most notably PCR amplifica-
tion. Beer et al.17 demonstrated the ability of single copies of DNA to be PCR amplified and detected in 10 picoli-
tre droplets. In this way, absolute quantification of initial DNA template is achievable by using multiple droplets 
at low copy number and applying Poisson  statistics18. In such digital PCR (dPCR), each droplet originating from 
a sample can be considered its own micro-assay, and thus mass throughput can be achieved by rapidly producing 
microfluidic droplets creating multiple compartments of a single  sample19. In addition multiplexing probes via 
the use of different fluorophores, or different fluorescent intensities per probe can expand assay  capacity20. Due 
to the benefits offered by dPCR vs  qPCR21, the technology is now commercialised and has occupied the niche 
of ultra-sensitive DNA template  quantification22.
In microfluidic PCR, thermocycling remains an important challenge which at times can be exacerbated by 
miniaturization and microfluidic  implementation23, alongside challenges in device  integration23,24. This is par-
ticularly challenging in dPCR where homogenous amplification is essential. For these reasons, high-sensitivity, 
isothermal methods of DNA amplification such as LAMP–BART provide an alternative, with potential to sim-
plify operation and implementation, as well as affording opportunity to operate without sample clean-up. To 
date proof-of-concept demonstrations of isothermal DNA amplification via LAMP in single phase microfluidic 
systems have been  demonstrated25–28, as well as demonstrations of droplet-based  LAMP29–31, and a number of 
paper-based microfluidic LAMP  devices32–35, including more recently for Covid-1936. However, to date, this has 
been in the absence of an integrated real-time quantitative readout e.g. in the form of a coupled biochemical or 
bioluminescent reaction such as BART. In this context, only two examples of microfluidic LAMP–BART exist 
to  date37,38, both describing on-chip single phase approaches with a single sample. As such, there is significant 
opportunity for the scaling of LAMP–BART approaches using droplet microfluidics to create multiple segregated 
low-volume assay containers for high-throughput, quantitative assessment.
There is much emerging interest in harnessing the advantages afforded by microfluidic compartmentalisation 
for biochemical reactions within more sophisticated multicompartmentalised, or biochemically fuctionalised 
artifical  cells39–41. With anticipation of such systems, inspired by biological cells, forming a next generation of 
smart soft-matter devices, with applications spanning the development of smart therapeutic delivery systems 
and freestanding smart  biosensors42. The ability to identify, amplify and respond to target nucleic acid sequences 
in such systems opens opportunities for both innovative diagnostics and would provide new chemical processes 
that can link to other biochemical mechanisms in such systems, increasing the scope of functionality.
Multicompartment droplet architectures incorporating lipid bilayers akin to biological  membranes40,43 rep-
resent a promising chassis system allowing harnessing of lipid bilayer barrier properties and incorporation of 
functional membrane proteins. DNA expression through in vitro transcription and translation (IVTT) has 
been demonstrated in such droplet interface bilayers systems, along with the ability to incorporate subsequently 
expressed protein channels in their lipid  bilayers44–46, enabling selective communication between compartments. 
Such membrane segregated aqueous droplet networks may be encased within a hydrogel  shell47, allowing them 
to be stable and freestanding in an aqueous environment, and stored for later use. The presence of lipid bilayers 
between the internal droplets and the external environment establishes a route for the controlled biomimetic 
communication between internal and external  environments48. As such, there is a significant opportunity for 
the incorporation of LAMP–BART DNA amplification and detection into artificial cells of this nature. This may 
enable freestanding micro DNA quantification vessels for sample analysis outside of laboratory environments, 
and also serve as a synthetic biology tool to enable DNA amplification and biochemical process coupling, in this 
case light emission, in response to small quantities of target biomolecules.
Here, the amplification and bioluminescent detection of DNA template using LAMP–BART in microfluidi-
cally generated droplets is demonstrated. A gradient of DNA concentrations across a series of droplets measured 
in parallel demonstrates the light emission dependency on DNA concentration, providing the opportunity for 
quantitative, low volume, high-throughput assays. Furthermore, the ability to perform LAMP–BART within 
the internal aqueous droplets of eDIB artificial cells is demonstrated quantifying light emission from individual 
cores, paving the way for free-standing soft-matter analytical devices.
Results
LAMP–BART droplets in tubing. LAMP–BART droplets without DNA template or with template were 
parked in tubing for analysis. Two LAMP assays were used targeting DNA sequences for the 35S promoter 
(35Sp) and NOS terminator (NOSt), both of which have been extensively studied for sensitivity and specificity 
in previous  publications7,8,11,16. Microfluidic droplets of LAMP–BART reagents with or without DNA template 
at 1 × 108 copies of the NOSt DNA template per droplet were generated and parked within tubing (Fig. 2). The 
flow rates of 4.0 millilitres per hour for the LAMP–BART reagents and 9.0 millilitres per hour for the mineral oil 
ensured a steady production of evenly spaced droplets. The DNA amplification reaction was heat activated and 
4
Vol:.(1234567890)
Scientific Reports |        (2020) 10:21886  | https://doi.org/10.1038/s41598-020-78996-7
www.nature.com/scientificreports/
maintained and imaged at 60 °C. The limit of detection (LOD) for LAMP–BART droplets incorporating NOSt 
artificial DNA template is shown in Supplementary Information Figs. S1 and S2.
The total photon counts for each set of eight droplets averaged 1.81 × 105 counts ± 0.03 × 105 for samples 
without DNA and 1.75 × 105 counts ± 0.08 × 105 for samples with DNA. Samples both with and without DNA 
template gave rise to background levels of bioluminescence below the 2000 count level. Samples containing 
DNA template rapidly increased in bioluminescence giving rise to a peak light intensity (average Tmax 2.25 ± 
0.05 min), from which light output rapidly reduced to below background levels. All eight droplets gave rise to a 
bioluminescent peak within 3 min of heating, with little variation in peak light intensity. LAMP amplification of 
the DNA template and the BART detection were both achieved from the nanoliter volume of the droplets and 
no LAMP amplification from contamination was detected in the no template controls (NTCs).
Figure 2.  LAMP–BART droplets in the absence (a) and presence (b) of DNA template. Artificial template 
(NOSt) at 1 × 108 copies per droplet with NOSt LAMP primers. (a) LAMP–BART no template control (NTC) 
in droplets, (b) LAMP–BART with DNA template. (i) Pre-acquisition image showing the position of droplets 
within the microfluidic tubing overlaid with maximum photon counts from the bioluminescent reaction within 
the droplets. A high intensity maximum is observed in the presence of DNA template (b) (ii) total photon 
counts for each droplet number indicate comparable total photon yields indicative of the uniformity of droplet 
size and homogeneity of low volume reactants. (iii) Real time photon counts from individual droplets show a 
rapid peak in light intensity with the inclusion of DNA template (b), which is absent in droplets without DNA 
(a) (Supplementary Information, Videos 1 and 2). The target droplet diameter was 500 micrometers. Variation 
in droplet size is shown in Supplementary information, Sect. 3. The limit of quantification of the NOSt artificial 
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LAMP–BART droplets off-chip. LAMP–BART droplets with DNA template were analysed off-chip. 
Microfluidically-produced droplets were output into a petri dish in NOVEC 7500 oil containing 2 percent Pico-
surf surfactant overlaid with mineral oil.
The LAMP–BART droplets clustered together without merging in the presence of Picosurf surfactant (Fig. 3a). 
Although care was taken to keep the droplets localised centrally in the well, the transfer to the imager caused 
movement to the side and this is evident from the change in droplet positions in the total photon count image 
(Fig. 3b). The bioluminescence from the droplets is discrete and regions of interest (ROIs) were assigned for 
seven nearest the centre. There is increased variability for the total photon counts for these ROIs (Fig. 3c) when 
compared to those droplets physically separated in tubing (Fig. 2). This variability is also evident with the real 
time photon counts which retain a rapid time-to-peak (average Tmax 1.65 ± 0.31 min) but without the smooth 
emission profile seen with physically constrained droplets, possibly due to the addition of surfactant affecting 
interfacial chemistry. The thermostability and uniformity of LAMP–BART droplets under mineral oil are shown 
in Supplementary Information Figs. S3 and S4 respectively.
DNA gradient of LAMP–BART droplets. LAMP–BART droplets with a gradient of DNA concentrations 
were generated. To demonstrate the control over the components forming the droplets and to show the DNA 
concentration dependent bioluminescent response, a DNA concentration gradient was established ranging from 
8.7 × 109 copies per droplet to 0 copies per droplet. A schematic of the droplet generation is shown in Fig. 4.
A DNA-template-positive LAMP–BART solution was mixed with a DNA-template-negative LAMP–BART 
solution at a varying ratio prior to droplet formation in order to generate LAMP–BART droplets of increasing 
concentration of DNA. These droplets were then parked in tubing for imaging. Selected ROIs from the full length 
of the tubing in the device were analysed to obtain BART peak data which showed initial rapid Tmax values (4.5 
min) declining to slower and subsequently no observable peaks within the measurement timeframe (Fig. 4iii), 
as DNA template was diluted in successive droplets. The gradient was further interrogated between ROIs 14 and 
17, where a further subset of ROIs between these markers was investigated highlighting the increase in Tmax 
Figure 3.  Multiple microfluidically produced surfactant stabilised LAMP–BART droplets are measured 
in a Petri dish. Artificial template (35Sp) at 2.6 × 108 copies per droplet with 35Sp LAMP primers. Non-
merging, discrete droplets were observed with a rapid bioluminescent light output evidencing successful DNA 
amplification (a) LAMP–BART droplets with blue dye (the dye was added for visualisation but removed from 
the experimental LAMP–BART reagent) in NOVEC PicoSurf under mineral oil photographed before transfer 
to photon imager, (b) pre-acquisition image showing the position of the droplets with total photon counts from 
the bioluminescent reactions overlaid. Regions of interest (ROIs) corresponding to individual droplets 1–7 are 
indicated, (c) total photon counts for each ROI, (d) real time photon counts from each ROI (Supplementary 
Information, thermostability; Fig. S3 and uniformity; Fig. S4, Video 3).
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Figure 4.  DNA template gradient within LAMP–BART droplets. Artificial template (35Sp) with input DNA concentration ranging 
from 8.7 × 109 copies per droplet to 0 copies per droplet. Output droplets parked in tubing at 60 °C for 30 min. Time to peak light 
response decreases with increasing DNA concentration of the droplets. (a) schematic of the LAMP–BART droplet generation with 
controlled DNA template gradient achieved by gradient modulation control of the relative flow rates of two aqueous sample inputs 
at the first T-junction, ahead of droplet formation. (bi) Pre-acquisition image showing the position of the tubing in the temperature 
controlled device with total photon counts from the bioluminescent reactions overlaid, (biii) regions of interests (ROIs) 1–20 
indicating a wide range of DNA concentrations from approximately 8.7 × 109 copies per droplet to the limit of detection and real time 
bioluminescence from each ROI, (bii) subset of ROIs numbered 1–20 from area highlighted in (bi), (biv) real time bioluminescence 
from this subset showing a narrower range of DNA concentrations. Amplification and detection of a range of DNA concentrations 
within the device by real time monitoring of light output is demonstrated with time to peak corresponding to initial DNA 
concentration. (Supplementary Information, Video 4, design of droplet water bath; Fig. S5, control experiment; Fig. S6).
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with reducing concentration of DNA template (Fig. 4iv). The details of DNA gradient generation are in Sup-
plementary Information Figs. S5 and S6.
LAMP–BART in compartmentalised artificial cells. LAMP–BART reagents and DNA template were 
encapsulated in droplets within a network of droplet interface bilayers. These droplets were microfluidically gen-
erated and encapsulated within a hydrogel shell (Fig. 5). Termed encapsulated droplet interface bilayers (eDIBs), 
they have been proposed as a chassis for artificial cells and freestanding analytical  devices47. We showed the suc-
cessful generation of eDIBs (Fig. 5) containing multiple droplets of LAMP–BART reagents and DNA template 
within the eDIB core. Furthermore, LAMP–BART droplets were stable within eDIBs, which were also tolerant of 
heating, allowing for DNA to be amplified and detected within such constructs. The microfluidically produced 
eDIBs were output into wells, heated to 60 °C and imaged, measuring the production of bioluminescent peaks 
characteristic of LAMP BART detection. This is in contrast to a control eDIB, which was deliberately ruptured 
within the well with a needle prior to heating, giving rise to coalescence between the internal droplets and the 
external buffer. The droplets within this eDIB coalesced with the surrounding aqueous environment within the 
well and no bioluminescence was recorded from this location (Fig. 5bi).
The eDIBs that were not ruptured remained stable at the LAMP–BART reaction temperature of 60 °C and 
throughout the 30 min assay. The location of the eDIBs is clear from the photon imaging (Fig. 5bi) however 
individual droplets within the eDIBs are not discernible using this imaging resolution. Baseline photon counting 
for each eDIB is broadly similar at the start of imaging acquisition. The variation in total photon counts (Fig. 5bii) 
from each eDIB is related to the BART peak heights at Tmax (Fig. 5biii) with counts at the BART peak rang-
ing from 3000 to 12,000. All seven intact eDIBs showed that the LAMP–BART reaction was successful with an 
average Tmax of 16.64 ± 1.34 min. LAMP–BART eDIBs containing DPhPC lipid are shown in Supplementary 
Information Fig. S7.
LAMP–BART in freestanding artificial cells with defined droplet numbers and tracking of bio-
luminescent signal. The ability to detect a unique LAMP–BART response for each droplet within an eDIB 
is demonstrated in Fig. 6. Here, eDIBs containing 2 and 3 internal aqueous cores are imaged using a macro imag-
ing module on the Photon Imager, measuring a unique bioluminescent response for each of the droplets within 
the eDIBs. Here, individual internal droplets of eDIBs remain segregated by an adjoining lipid membrane. Lipid 
bilayers also separate the internal droplets from the encapsulating hydrogel shell, providing a bio-mimetic plat-
form of membrane segregated compartments with the capability to harness membrane-mediated communica-
tion between neighbouring droplets and between droplets and the outside environment.
The total photon count images for the two and three core eDIBs show the movement of the droplets during 
the 20 min acquisition. The droplets were tracked using ImageJ software with the results off image intensity 
analysis following tracking are shown in Fig. 6, iii. The BART profiles are well defined with individual internal 
droplet tracking and quantification showing greater similarity to the BART profiles observed with droplets in 
tubing compared to the previous multiple core eDIBs measurements. The BART Tmax values for the two core 
eDIB were 12.8 and 10.2 min (average Tmax 11.5 ± 1.8) and 10.4, 9.0 and 9.0 min for triple core (average Tmax 
9.5 ± 0.8). Results for single and quadruple core eDIBs are shown in Supplementary Information, Fig. S8 with 
raw images of the experiments, Fig. S9.
Discussion
For the first time we have shown that microfluidic LAMP–BART droplets can be generated and that the light 
output from these droplets can be detected and quantified in real time. The uniformity of these droplets (Sup-
plementary Information, Fig. S4) was evident from the consistent photon counts from each one and represents 
a proof-of-concept that nanoscale LAMP–BART volumes are possible. Furthermore, multiple droplets can be 
generated enabling quantification from large numbers of partitions, illustrating the potential to be developed 
into droplet digital, or low-copy number peak-variance LAMP  quantification16 with dilute DNA samples. Posi-
tive LAMP–BART droplets were easily distinguishable in real time from negative control droplets, a feature 
important to a digital quantification approach.
Continuous observation of the dynamics of the bioluminescence provides rich information that informs on 
original DNA copy number in real time. This is a result of the combined effects of DNA amplification liberating 
PPi which subsequently generates ATP to energise bioluminescence, and at high concentrations PPi also serv-
ing to quench light emission. Thus the profile of light emission, rather than total photon counts, informs on the 
sequence copy number (Fig. 2bii; total photon counts, biii; maximum photon counts per droplet), yet retains 
a strong quantifiable signal regardless of initial template concentration. Thus the time to peak light emission 
informs on original copy number. By continuously imaging multiple droplets in parallel, large scalable meas-
urements can be conducted. These multiple simultaneous measurements may be harnessed for assessment of 
multiple partitions of a single sample for digital or time variance methods to quantity low copy number, or at 
high copy number they may represent different samples or targets. Attractively, in principle one methodological 
approach can operate in either regime by simply creating a microfluidic dilution series.
The physical constraint of droplets in tubing coupled with the high time and pixel resolution of the Biospace 
PhotonIMAGER Optima produce high quality BART profiles (Fig. 2biii) which can be used to further study 
LAMP amplification and BART detection. The average time to peak for the eight droplets of 2.25 min is extremely 
rapid for a molecular diagnostic assay and consistent with a standard deviation of 3 seconds (0.05 min). Simple 
mineral oil was sufficient for the oil phase for in-channel measurement, but the propagation of parked droplets 
into a well required NOVEC 7500 oil with 2 percent PicoSurf surfactant to prevent droplet coalescence. At 52 °C 
evaporation could be controlled by a requisite layer of mineral oil. A greater number of droplets can be parked 
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Figure 5.  LAMP–BART encapsulated droplet interface bilayers (eDIBs). eDIBs are artificial cell mimics 
comprised of lipid membrane segregated droplet networks, encapsulated with a hydrogel shell. Artificial 
template (35Sp) at 2.6 × 108 copies per droplet with 35Sp LAMP primers. (ai) photograph of an (eDIB) within 
microfluidic outlet tubing containing seven aqueous LAMP–BART droplet cores. (aii,iii) Schematic of eDIB 
structure and principles of formation, self-assembled lipid monolayers at aqueous-oil interface are brought into 
contact to form artificial lipid bilayers, these are formed between aqueous droplets within an oil droplet, which 
is subsequently encapsulated in a hydrogel shell, where lipid bilayers also form where the internal droplets 
and hydrogel shell interfaces contact. The resultant structure comprises lipid bilayer segregated and stabilised 
droplet compartments within a hydrogel shell. These constructs were output from the microfluidic device into 
individual wells of a heating well plate (bi) image of total photon counts for eDIBs numbered 1–8, number 6 
represents a control well where the eDIB was ruptured prior to imaging, (bii) total photon counts from eDIBs 
1–8 and (biii) real time photon counts from each eDIB. The encapsulated LAMP–BART eDIB droplets are 
mechanically and thermally stable, and triggerable by the required reaction temperature. (Supplementary 
Information, Video 5; LAMP–BART eDIBs formed with DPhPC lipid only, Fig. S7).
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within a given area by this method but challenges still remain in preventing droplet fusion at higher reaction 
temperatures. The optimal temperature for LAMP–BART is 60 °C, determined by a compromise between Bst 
DNA polymerase activity and thermostability of the UltraGlo luciferase, and indeed higher temperatures for 
LAMP have been used with other detection methods. A broader peak was observed in these packed droplets 
off-chip (Fig. 3d) than when parked within a microfluidic channel, suggesting sub-optimal amplification pos-
sibly from the reduced assay temperature. Also the increased variation between Tmax values coupled with the 
Figure 6.  Two and three core LAMP–BART eDIBs with real-time tracking and quantification of light emission. 
Artificial template (35Sp) at 2.6 × 108 copies per droplet with 35Sp LAMP primers. (a) Imaging of encapsulated 
droplet interface bilayer (eDIB) containing two internal droplets, (b) imaging of triple droplet eDIB, (i) pre-
acquisition photographic images showing the eDIBs in the microfluidic tube following their production. These 
eDIBs were then output into aqueous containing wells where they remained unconstrained for the imaging of 
the LAMP–BART reaction. (ii) total photon counts images from the eDIBs with the positions of ROIs for real 
time analysis, (iii) real time bioluminescent output results from each Internal droplet of the eDIB extracted 
following tracking with ImageJ, (iv–vii) image sequence shows the successive movement and tracking of the 
eDIBs whilst DNA amplification and light emission takes place, with distinct signal measured from each 
membrane serrated aqueous droplet. Defined numbers of internal droplets can be generated and encapsulated in 
eDIBs with LAMP–BART eDIBs can be tracked in real time for accurate result from each cores. (Supplementary 
Information, Fig. S8; Video 6).
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broader BART peaks may be explained by differences at the droplet interface, for example from contact between 
droplets, air, surfactant, and plasticware.
The ability to control the components of the aqueous droplets as well as the volume, the rate of generation 
and the propagated number of droplets is important in such areas as DNA quantification, single copy number 
detection and synthetic biology. We showed in the generation of DNA gradients (Fig. 4) that the DNA composi-
tion of the droplets was controlled in conjunction with the flow rate and the droplet size. The increasing DNA 
concentration showed a decrease in Tmax values to less than 5 min for droplets at the high DNA concentration 
(approximately  109 copies per droplet) end of the tubing. We note that the controlled dilution of a sample with 
LAMP–BART quantification could be used to remove the effect of an inhibitory substance such as  SDS11 through 
dilution to gain a more accurate quantification.
The experiments performed here with eDIBs represent the first DNA amplification and detection reported 
in an artificial cell chassis, achieved here via LAMP coupled to bioluminescent reporting. LAMP–BART within 
eDIBs containing a number of internal cores (3-4 cores) displayed peaks in bioluminescence upon heating to 60 
°C, confirming amplification of the DNA sample. The eDIBs were observed to remain intact during the course 
of the experiments, and droplet tracking imaging software could accommodate accurate quantification of light 
emission from individual cores even whilst unconstrained eDIBs moved during the course of the experiment.
Tmax for the eDIBs exhibited a larger variance (16.64 ± 1.34 min) in comparison to results obtained for aque-
ous droplets in oil (2.25 ± 0.05 min), as well as broader peaks. However, both droplets in eDIBs and aqueous 
droplets are of similar size and volume. This difference might be explained by heterogeneous heating in eDIBs, 
or disruptive interactions between the LAMP–BART reaction components and the lipid-rich droplet interface. 
Additionally, Tween-20 was removed from the LAMP–BART cocktail as it was expected that surfactant species 
would interfere with lipid bilayer formation at the droplet interfaces. It was also found that the incorporation of 
lipid with polyethylene glycol (PEG) attached to the lipid head, was an important factor in obtaining a cleaner 
LAMP–BART bioluminescence profile over time, as LAMP–BART occurring in eDIBs containing only the lipid 
DPhPC exhibited a more erratic bioluminescent profile as well as broader peaks (Supplementary Information, 
Fig. S7). Consequently a lipid cocktail composed of 50 percent DPhPC and 50 percent DSPE-PEG2000 was 
employed for the experiments reported here. This strategy was reported by Booth et al43. to optimise in vitro 
transcription and translation (IVTT) in lipid-bound droplets, and it is theorized that the PEG may provide a 
steric or electrostatic barrier between the droplet contents and the droplet interface, minimizing unwanted lipid-
protein or lipid-nucleic acid interactions that might interfere with the LAMP–BART reaction.
A further experiment aimed at determining whether bioluminescence traces could be detected from indi-
vidual eDIB cores, and for this eDIBs containing two or three cores were imaged using a macro lens (Fig. 6). The 
internal droplets exhibited unique bioluminescent profiles with an average Tmax of 16.28 ± 1.55 min for all 5 
droplets measured, demonstrating that each droplet within an eDIB can be considered an individual assay unit. 
This may explain the broader peaks displayed in their collective measurement (Fig. 5), as they are likely to be an 
ensemble measurement of all of the droplets contained within.
These experiments provide a proof-of-concept for DNA to be amplified and detected within the droplets of an 
eDIB artificial cells. This represents a foundation for the use of eDIBs as stable, storable, self-contained analytical 
devices to detect specific DNA sequences in liquid samples. The multicompartment nature of the eDIB constructs 
may allow for multiple assays to take place within a single eDIB, for example. Or the network may be harnessed 
to combine with more complex chemical processing via the transport of molecular species through pores or 
channels within the lipid bilayers of the droplet network, linking otherwise segregated reaction chemistries. In 
this context, networked and sequential reactions in droplet networks have recently been demonstrated, using 
membrane proteins to control chemical communication and reaction initiation within such  networks49,50. The 
ability to undertake sequence specific nucleic acid amplification and detection adds to the toolkit of available 
functional biochemistry in these systems. In combination, such approaches could be harnessed to transport 
DNA into internal compartments of eDIBs for subsequent LAMP amplification and BART detection. Similarly 
nanopore DNA sequencing approaches have been applied in droplet interface  bilayers51,52 and could be combined 
with preceding in situ LAMP amplification within the droplet itself for efficient sample  multiplexing53. In situ 
protein expression has been demonstrated in Droplet Interface Bilayer networks with subsequently expressed 
protein channels able to incorporate into the lipid  bilayers44–46, in addition to demonstrations of in vitro gene 
circuits within droplet  networks54. In situ LAMP–BART combined with these approaches could further enable 
complex multistep compartmentalised functionality more akin to biological cells. Furthermore, low copy DNA 
sequence specific triggers may be harnessed with LAMP within droplet networks, to generate and amplify 
coupled biochemical responses energised via the associated avalanched generation of pyrophosphate from the 
LAMP reaction which is subsequently converted to ATP. This is exemplified here in the form of light emission, 
with the temporal growth and subsequent inhibition of light emission determined by DNA concentration. In 
addition to application in soft-matter diagnostic devices, this approach could be harnessed as a generic reporting 
mechanism in smart artificial cells, or coupled to other ATP dependent biochemistries as a means for artificial 
cell energisation.
These experiments provide a proof-of-concept for DNA to be amplified and detected within the droplets 
of an eDIB artificial cells. This represents a foundation for the use of eDIBs as stable, storable, self-contained 
analytical devices to detect specific DNA sequences in liquid samples. Membrane protein channels have been 
shown to be able to insert in the lipid bilayers of  eDIBs47, and could be used to transport DNA into its internal 
compartments for subsequent LAMP amplification and BART detection. Similarly nanopore DNA sequencing 
approaches have been applied in droplet interface  bilayers51,52 and could be combined with preceding in situ 
LAMP amplification within the droplet itself. DNA expression through in vitro transcription and translation 
(IVTT) has been demonstrated in similar droplet interface bilayers systems, along with the ability to incorporate 
subsequently expressed protein channels in their lipid  bilayers44–46, in combination this would enable multistep 
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compartmentalised functionality akin to biological cells. In this regard, the multicompartment nature of the 
eDIB constructs may allow for multiple assays to take place within a single eDIB, for example. Or for more com-
plex chemical processing to occur via the transport of molecular species through pores or channels within the 
lipid bilayers of the droplet network to link otherwise segregated reaction chemistries. Furthermore, low copy 
DNA sequence specific triggers may be harnessed with LAMP, to generate and amplify coupled biochemical 
responses energised via the associated avalanched generation of pyrophosphate from the LAMP reaction which 
is subsequently converted to ATP. This is exemplified here in the form of light emitting artificial cells, with the 
temporal growth and subsequent inhibition of light emission determined by DNA concentration. In addition to 
application in soft-matter diagnostic devices for DNA detection, this approach could be harnessed as a generic 
reporting mechanism in smart artificial cells, or coupled to other ATP dependent biochemistries as a means for 
artificial cell energisation.
Conclusions
Microfluidic LAMP–BART droplets provide stable, low volume, high throughput partitions for applications in 
DNA detection and quantification. Multiple droplets with uniformity of scale could form the basis of a digital 
LAMP–BART assay for absolute quantification of low concentrations of DNA targets from statistical analysis 
of positive and negative bioluminescent droplets. Smaller droplets would enable a greater number of individual 
reaction partitions from a sample volume for more accurate digital quantification. Increased sophistication of 
microfluidic liquid handling could ultimately enable analysis of multiple samples and multiple targets.
We achieved the incorporation of defined numbers of LAMP–BART droplets into eDIB artificial cells, ena-
bling the reaction to be triggered by temperature and detected in real time by counting photons emitted. This 
control over the droplets and the development of more complex microfluidics would allow the incorporation of 
droplets composed of differing chemistries to provide the means to study, or exploit, complex DIB networking 
within individual eDIBs. The LAMP–BART eDIBs could be used as artificial cells to study their interaction with 
environmental conditions and provide the potential to transport DNA across the lipid bilayer to react with the 
LAMP–BART reagents. This would create the possibility of assessing multiple DNA targets in an array of eDIBs 
for the detection of single nucleotide polymorphisms (SNPs) and genetic variants in clinical samples.
Methods
LAMP–BART reagent preparation. Unless otherwise stated, all reagents were supplied by Sigma (Poole, 
United Kingdom). As previously  described14 but with some modification, the LAMP amplification with BART 
detection reaction mixture contained 1X isothermal buffer (20 millimolar Tris-HCl, 10 millimolar ammonium 
sulphate, 50 millimolar potassium chloride (KCl), 2 millimolar magnesium sulphate, pH 8.8), 5 micrograms 
salmon sperm carrier DNA, 60 millimolar KCl, 0.4 milligrams per millilitre polyvinylpyrrolidone (PVP), 10 
millimolar dithiothreitol (DTT), 300 micromolar each deoxynucleotide triphosphate (dNTP), 100 micrograms 
per millilitre D-luciferin (Europa, Ipswich, United Kingdom), 250 micromolar adenosine-5′-O-phosphosulfate 
(APS; Biolog, Bremen, Germany), 5.5 micrograms per millilitre Ultra-Glo luciferase (Promega, Madison, United 
States), 0.32 units per millilitre Bst polymerase v2.0 warm start (NEB), 0.375 units per millilitre ATP sulfury-
lase (NEB), 0.2 micromolar each displacement primer, 0.4 micromolar each Loop primer, 0.8 micromolar each 
LAMP primer and molecular grade water for a total reaction volume of 500 millilitres.
Oligonucleotide primers and artificial templates. All oligonucleotide primers for LAMP amplifica-
tion were synthesized and HPLC purified by Sigma (Supplementary Information, Table S1). All primers were 
diluted to a stock concentration of 100 micromolar and stored at − 20 °C. Artificial templates (Supplementary 
Information, Table S2) for 35S promoter and NOS terminator LAMP primers were synthesized by Integrated 
DNA Technologies (IDT; Iowa, United States) with PAGE purification. The 150 and 176 base oligonucleotides 
were diluted to (10 micromolar) and stored at − 20 °C. The artificial templates were designed to form looped 
secondary structures based on the cycling LAMP “dumbbells” to provide rapid amplification at high concentra-
tion. 35S promoter and NOS terminator LAMP assays were selected due to extensive previous studies with these 
 primers7,8,11,16.
Microfluidic reagent preparation. Mineral oil (Sigma) formed the oil phase for droplets in tubing 
(Fig. 2). For parked droplets, mineral oil was replaced with NOVEC 7500 2 percent w/w PicoSurf (Sphere Fluid-
ics, Cambridge, UK) and the droplets were generated into NOVEC 7500 2 percent w/w PicoSurf under a layer 
of mineral oil in a cell culture plate (Eppendorf, Hamburg, Germany) (Fig. 3). For eDIBs the internal oil phase 
consisted of 4 milligrams per millilitre lipid solution (50 percent DPhPC and 50 percent DSPE-PEG2000; Avanti 
Polar Lipids, Alabama, USA) in hexadecane and silicone oil AR20 (2:1). The alginate phase consisted of 2 percent 
w/v low viscosity alginate with 50 milligrams per millilitre nanoparticulate calcium carbonate, adjusted to 0.1 
molar ionic strength using sodium chloride. The external oil phase consisted of mineral oil with 0.5 percent v/v 
glacial acetic acid.
Droplet propagation with infusion pumps. Two Graseby (Smiths Medical, Minneapolis, USA) 3150 
automatic infusion pumps were modified to flow fluids from 10 millilitre Luer lock syringes connected with Luer 
to 10-32 coned connectors (Upchurch Scientific, IDEX, Illinois, USA) and fingertight fittings (IDEX) through 
0.5 millimetre inner diameter (ID) fluorinated ethylene propylene (FEP) tubing (IDEX). Aqueous droplets were 
generated in the oil phase within a Tee junction (IDEX) with 1/16th of an inch outer diameter (OD) connectors. 
Lengths of tubing containing droplets were cut for analysis, or the droplets were flowed into a device. Lengths of 
tubing containing eight droplets were appropriate for the field of view with macro imaging.
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DNA gradient. In order to produce a gradient of DNA across a number of droplets, an additional T-junction 
was added upstream of the aqueous input into the droplet-generating T-junction. The inputs into this T-junction 
consisted of LAMP–BART solutions, one containing 1.3 × 1011 copies of the DNA target per microlitre, and the 
other containing no DNA. A LabVIEW (Austin, Texas, USA) 2017 protocol was used to control the syringe 
pump flow rates of both the LAMP–BART solutions to produce a continuous gradient of DNA concentration at 
a fixed total flow rate. The total output flow rate was maintained at 1 millilitre per hour in order to ensure consist-
ent droplet generation at the downstream T-junction where the oil phase was mineral oil at 2 millilitre per hour.
Production of eDIBs. The eDIBs were produced using a purpose-built microfluidic device as  described47. 
Fluids were flowed using Legato series syringe pumps (KD Scientific, USA), at a rate of 1:8:150:200 millilitre 
per hour, for the internal aqueous, lipid in oil, alginate, and acid in oil solutions, respectively. This gave rise to 
eDIBs containing 1 or 2 internal aqueous cores, and by changing the internal aqueous flow rate to 2 millilitre per 
hour, eDIBs were produced with 3–4 cores. The eDIBs were then parked in the final FEP tube of the microfluidic 
device and outputted individually into wells by flowing the alginate fluid at a manageable flow of 50 millilitre 
per hour.
DNA amplification. The warm start displacement polymerase is activated above 45 °C triggering the 
LAMP amplification using a Torrey Pines (San Diego, California, USA) modified programmable heat block set 
at 52 or 60 °C. The cut lengths of tubing and cell culture plates with parked droplets were placed directly onto 
the heated surface. Pre-heated glycerol at 60 °C was added to the water bath device on the heat block to start 
the LAMP reaction. The cut tubing, parked droplets and eDIBs were carefully disposed of post amplification to 
reduce contamination risk.
Bioluminescent imaging. All imaging of the bioluminescent LAMP–BART reaction in real-time utilised 
the PhotonIMAGER Optima (Biospace Lab, Nesles-la-Vallée, France). Either the 55 millimetre lens or macro 
module, for increased pixel resolution, was used depending on the required field of view. Pre-acquisition illu-
minated imaging was used to locate the droplets and eDIBs and provide a background for the bioluminescent 
acquisition images. Imaging was terminated manually after BART peaks had been observed, between 10 and 
30 min from the start. For large data files, BVR reduction software (Biospace Lab, Nesles-la-Vallée, France) was 
used to reduce the number of pixels used for analysis. The data was analysed using M3 Vision software (Biospace 
Lab, Nesles-la-Vallée, France) version 1.1.2.26170, Microsoft Excel and Graphpad PRISM version 8.3.
Real-time tracking of bioluminescence. The quantification of LAMP–BART in individual cores of 
eDIBs was performed by conducting individual core-tracking using the ImageJ plugin  trackmate55 included 
in the FIJI distribution of ImageJ (version 2.0.0)56. Spatially correlated photon counting data from the Photon 
Imager was exported as TIFF image stack, with data integrated over a period of 1200 seconds to give a frame rate 
of 1 frame per 13.3 seconds. To enhance tracking efficiency, signal to noise was enhanced by employing a Gauss-
ian blur (width = 2 pixels, depth = 1 frame) to minimize background noise prior to tracking. Trajectory linking 
employed maximum linking and gap-closing distances of 20 pixels, with a maximum gap-closing frame gap of 
two frames. Intensity data was then extracted from the tracked bioluminescent cores for quantitative analysis.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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